REQUEST A DEMO
Total
USD $0.00
Search more companies

Kansuk Laboratuari A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Kansuk Laboratuari Sanayi Ve Ticaret Anonim Sirketi Profile Updated: October 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Kansuk Laboratuarı San. Ve. Tic. A.ş is a Turkish pharmaceutical company that specializes in the production of blood components, pharmaceuticals, and medicinal products for human use. Kansuk Pharmaceuticals operates a GMP-approved production facility and holds ISO 13485:2016 Medical Devices and CE certification for sterile medical devices. The company aims to provide high-quality service to the Turkish pharmaceutical industry and focuses on attracting and retaining qualified human resources.

Headquarters
No:14-1 Yassioren Mahallesi Firat Sokak Arnavutkoy
Istanbul; Marmara; Postal Code: 34277

Contact Details: Purchase the Kansuk Laboratuari A.S. report to view the information.

Website: http://www.kansuk.com

Basic Information
Total Employees:
Purchase the Kansuk Laboratuari A.S. report to view the information.
Outstanding Shares:
Purchase the Kansuk Laboratuari A.S. report to view the information.
Incorporation Date:
March 07, 1960
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Kansuk Laboratuari A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
114.76%
Total operating revenue
114.76%
Operating profit (EBIT)
42.47%
Net Profit (Loss) for the Period
-7.43%
Total assets
173.95%
Total equity
200.05%
Operating Profit Margin (ROS)
-8.38%
Net Profit Margin
-10.89%
Return on Equity (ROE)
-28.14%
Debt to Equity Ratio
-14.98%
Quick Ratio
-0.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?